Document is current
Any future updates will be listed below
-
Authors
Otowa-Suematsu, Natsu
Nakamura, Tomoaki
Miura, Hiroshi
Yamada, Tomoko
Nishisaka, Marika
Fukumitsu, Hayato
Katsura, Yukari
Morita, Yasuko
Asahara, Shun-Ichiro
Sakaguchi, Kazuhiko https://orcid.org/0000-0003-1577-2401
-
Funding
Funding for this research was provided by:
Kobe University
- License Information
-
More Information
Article History
Received: 25 November 2025
Accepted: 16 February 2026
First Online: 5 April 2026
Declarations
:
: K. S. reported honoraria for lectures from Sumitomo Pharma, Novartis Pharma KK, Otsuka Pharmaceutical, Novo Nordisk Pharma, and Sanofi KK, as well as research funding from Sumitomo Pharma. All remaining authors declare no conflict of interest.
: This study protocol was approved by the Ethics Review Committee of Kobe University Hospital (Approval No. 1834; approved on 4 November, 2015]) and was conducted in accordance with the Declaration of Helsinki and its amendments.
: Written informed consent was obtained from all participants included in this study.
